[27P01-234S] Investigation of recognition of diet therapy and association with glycemic control in type 2 diabetes patients

○Takehiro Ogawa¹, Takeo Iwata¹, Kikuji Yamashita¹, Yoshiko Tominaga² (1. Fac.Pharm, Niigata Univ. Pharm Applied Life Sci., 2. Collab Center Health Prom, Niigata Univ. Pharm Applied Life Sci.)

[27P01-235S] Relationship between leftover medicine and lifestyle of dialysis patients

○Rina Odahara¹, Takahiro Nisi², Hiroko Yamakawa², Nobuhiro Nagasaki¹, Yuuko Saruhashi¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences , Fukuyama University, 2. Nisi Clinic)

[27P01-236S] Residual drug survey and drug costs for dialysis patients

○Naruho Sirakihara¹, Takahiro Nisi², Hiroko Yamakawa², Nobuhiro Nagasaki¹, Yuuko Saruhashi¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences , Fukuyama University, 2. Nisi Clinic)

[27P01-237S] A text analysis of the support that pharmacists devise to prevent self-interruption of medication in depressed patients

○Atsushi Shimada¹, Masaki Shoji¹, Atsuko Fujiwara², Mitsuko Onda¹ (1. Osaka University of Pharmaceutical Sciences , 2. Apis Pharmacy Co.Ltd)

[27P01-238S] A Study on the Use of Questionnaire Simplification Protocols

○Kazuhide Ota¹, Yuto Akaba¹, Daigo Kasahara¹, Naotaka Son², Takeshi Kuwahara³, Koichi Masuyama¹, Kunihiko Kitagaki¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Pharmacy Inc., 3. Japanese Society of Hospital Pharmacists)

[27P01-239S] Analysis of the characteristics of pharmacies and pharmacists on question inquiry

○Yuto Akaba¹, Masaki Narahara¹, Kazuhide Ota¹, Naotaka Son², Keiichi Chin¹, Takashi Kuwahara³, Koichi Masuyama¹, Kunihiko Kitagaki¹ (1. Tokyo University of Pharmacy and Life Sciences , 2. Pharmacy Inc., 3. Japanese Society of Hospital Pharmacists)

[27P01-240S] A study of dietary advice by pharmacists and their collaboration with nutritionists at community pharmacies

○Misuzu Tanabe¹, Takeo Iwata¹, Kikuji Yamashita¹, Yoshiko Tominaga² (1. Fac. Pharm, Niigata Univ. Pharm Applied Life Sci., 2. Collab Center Health Prom., Niigata Univ. Pharm Applied Life Sci.)

[27P01-241S] The current state of pharmacist work and extraction of issues for promoting interpersonal work

○Ayaka Sakurada¹, Noriko Kobayashi^1,2, Kazuko Fujimoto¹, Hiroki Iwata^1,2, Katsunori Yamaura^1,2 (1. Keio Univ Faculty Pharm, 2. Keio Univ Commun Pharm)

[27P01-242] Research of the patient Information at "Okusuri-Techo" and Analysis of the factors that affect the contents

○Keiko (Sasaki) Akagawa¹, Norimi Kimura¹, Ryota Kumaki¹, Naomi Kurata¹, Keiko Kishimoto¹ (1. Division of Social Pharmacy , Showa Univ.)

[27P01-243] Efforts to COVID-19 by Midori pharmacy as “a health support pharmacy”

○Mizuki Tanaka¹, Yukiha Tanaka¹, Chisayo Hakuno¹, Mayumi Sakaguchi¹ (1. Midori pharmacy)

[27P01-244S] Multiple-Choice Questionnaire Survey for Lifestyle-Related Disease Prevention Consciousness: A Genetic Analysis among Pharmacy Staff and the General Population

○Yuka Horioka¹, Akihiro Michihara¹, Toshiya Sadamitsu¹, Aldo Sueda¹, Yukako Sunami¹ (1. Fukuyama Univ.)

[27P01-245] Questionnaire survey on ointment adhesion and its characteristics

○Shizuko Maeda¹, Mai Sasaki¹, Yoshitaka Tayama¹, Kazumi Sugihara¹, Katsushi Miyake¹ (1. Fac. Pharm. Sci.,Hiroshima Intl. Univ.)

Withdrawn

[27P01-246] [Withdrawn]

[27P01-247] Evaluating patients' concerns extracted from the questionnaire of Thalidomide Education and Risk Management System using topic model

○Kousuke Okamoto¹, Yu-Shi Tian², Tatsuya Takagi² (1. Faculty of Pharm. Sci., Hokuriku Univ., 2. Grad. School of Pharm. Sci., Osaka Univ.)

[27P01-248] Positioning of Levonorgestrel in Japan-Current Situation and Issues of Sex Education in Japan-

○Mikako Nakamura¹, Noriko Fukushima¹ (1. Social pharmacy.,Teikyouheisei Univ.)

[27P01-249] Comprehensive analysis of candidate off-target mutation sites caused by CRISPR-Cas9 genome editing therapy

○Takuma Yamashita¹, Yuki Naito², Takenori Yamamoto¹, Tokuyuki Yoshida¹, Takao Inoue¹, Eriko Uchida¹ (1. NIHS, 2. DBCLS)

[27P01-250] Exploring biomarkers for early screening of liver carcinogens using tissue samples in nonclinical trials

○Jun-ichi Akagi¹, Young-Man Cho¹, Takeshi Toyoda¹, Yasuko Mizuta¹, Kumiko Ogawa¹ (1. Div. Pathol., Natl. Inst. Health Sci.)

[27P01-251] Evaluation of adverse events of triazolam in elderly patients

○Akira Okada^1,2, Natsuko Takano¹, Shoji Sera^1,2, Naomi Nagai^1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)

[27P01-252S] Analysis of adverse events in each lipid emulsions using the US spontaneous report database

○Yuta Nagashima¹, Akira Okada^1,2, Shoji Sera^1,2, Naomi Nagai^1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)

[27P01-253] Current status of the EP and the USP-NF regarding the functionality-related characteristics of excipients

○Tamaki Miyazaki¹, Hitomi Kanno¹, Daisuke Ando¹, Eiichi Yamamoto¹, Ken-ichi Izutsu¹ (1. Division of Drugs, NIHS)

[27P01-254] Comparison of scientific names described in The Japanese Standards of Quasi-Drug Ingredients and those used in taxonomy

○Takumi Akiyama¹, Yoshiaki Ikarashi¹ (1. Natl. Inst. Health Sci.)

[27P01-255] Survey of revised package inserts of over-the-counter drugs in the common cold treatment.

○Akinori Shintani¹, Akira Hihara¹, Hiroaki Yamada¹ (1. YOKOHAMA UNIVERSITY OF PHARMACY)

[27P01-256] Study for pharmaceutical companies on advertising of over-the-counter drugs associated with Revised Code of Fair Practices in the Advertising of Drug and Related Product

○Yuko Kobuke¹, Kozue Imai³, Marina Tanaka¹, Toshio Kubota¹, Itsuko Horiguchi² (1. Daiichi Univ. Pharm., 2. Pharmaceut. Sci., Tokyo Univ.Science, 3. Former Japan Self-Medication Industry)

[27P01-257S] Comprehensive Survey Analysis of the Last Two Decades on Drugs Approved by Public Knowledge-based Applications in Japan and Assessment of Trends

○Yuka Fukuda¹, Marika Uchida¹, Hideki Maeda¹ (1. Dept. Regulatory Science, Meiji Pharmaceutical University)

[27P01-258S] Postmarketing safety of anticancer drugs approved before confirmatory phase Ⅲ trials in Japan

○Michiyuki Komiyama¹, Takayuki Miyazaki¹, Naoki Matsumaru¹, Katsura Tsukamoto¹ (1. Gifu Pharmaceutical Univ.)

[27P01-259S] Research on issues and points to consider for promoting corporate utilization of Real World Data(RWD) in Japan -Utilization of patient registry-

○masanobu isoyama¹, makio kamida¹, yuka hukushima¹, tomoka nakamura², akira kitagawa², kazuo izumi², mayumi shikano¹ (1. Tokyo Univ. of Science Pharm, 2. National Center for Global Health and Medicine)

[27P01-260] International trends in evaluation of efficacy and safety of switching patients between reference and biosimilar rituximab

○Tetsu Kobayashi¹, Hiroko Shibata¹, Akiko Ishii¹ (1. NIHS)

[27P01-261] International trends in evaluations of serological tests and establishment of the reference standard for anti-SARS-CoV-2 antibody

○Kazuko Nishimura¹, Hiroko Shibata¹, Yoshiro Saito², Akiko Ishii-Watabe¹ (1. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 2. Division of Medicinal Safety Science, National Institute of Health Sciences)

[27P01-262] Analytical performance evaluation of SARS-CoV-2 antibody test kits using anti-SARS-CoV-2 monoclonal antibodies

○Hiroko Shibata¹, Kazuko Nishimura¹, Chizuru Miyama¹, Yoshiro Saito², Akiko Ishii-Watabe¹ (1. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 2. Division of Medicinal Safety Science, National Institute of Health Sciences)

[27P01-263] Application of Analytical Quality by Design approach for development and change management of analytical method used for specifications of biopharmaceuticals

○Akiko Ishii-Watabe¹, Hiroko Shibata¹, Akira Harazono¹, Masashi Hyuga¹, Yukio Hiyama² (1. Division of Biological Chemistry and Biologicals, NIHS, 2. Division of Drugs, NIHS)

[27P01-264] Points to consider for host cell protein (HCP) quantification using ELISA.

○Masashi Hyuga¹, Minoru Tada¹, Akiko Ishii-Watabe¹ (1. National Institute of Health Sciences)

[27P01-265] Comparison of O-linked glycan profiles of etanercept innovator and biosimilar products by non-reductive beta-elimination using superbase and HPLC/FL

○Akira Harazono¹, Hiroko Shibata¹, Akiko Ishii¹ (1. DBCB, NIHS)

Session information

[27P01] 社会薬学
レギュラトリーサイエンス